Malaria Vaccine R&D Webinar – GVIRF 2022
In March 2022 Simon presented at the GVIRF Webinar: Malaria Vaccine R&D and Immunisation – Lessons Learned and Considerations for Global Health Impact.
The Global Vaccine and Immunisation Research Forum (GVIRF) is a global meeting that brings together the entire vaccine and immunisation research community, and is organised by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), the Bill & Melinda Gates Foundation (BMGF), and the World Health Organisation (WHO).
Significant challenges affect the development and implementation of vaccines targeting diseases prevalent in low- and middle-income countries. The first-generation malaria vaccine RTS,S/AS01 is an important advance in combatting a difficult pathogen and illustrates critical obstacles facing the vaccine and immunisation communities. Using RTS,S/AS01 as a case study, this webinar explored lessons learned and discussed vaccine R&D considerations for malaria and other diseases of global health importance prevalent in resource-limited settings.
Simon presented on “Technologic Approaches: Technologies for Subunit Malaria Vaccines” in the session entitled: “Vaccine Development Paradigms and Challenges: Strategic Consideration for Future Malaria Vaccines”. Other talks were given by colleagues from PATH, Sanaria and the Africa Centers for Disease Control and Prevention.
Other webinar topics included:
- The RTS,S/AS01 vaccine and lessons learned
- Future malaria R&D priorities and strategies
- Vaccine development hurdles and challenges
- Implementation and distribution considerations
- Manufacturing and accessibility impediments
- Safety and regulatory concerns
- Resources and global collaboration
